Further research is needed to better understand the interplay between the DA system, glutamatergic system, and other neurotransmitter systems to improve interventions for preventing and treating alcohol dependence
Reasons for low levels of initiation and long-term use of AOMs may include reluctance of public health and medical organizations to recognize obesity as a disease, lack of reimbursement, provider inexperience, and misperceptions about the efficacy and safety of available treatments
Laudenslager, who was not involved in the study, points out that it was observational in nature, meaning it looked at correlation not causation
While many of the supply chain issues with accessing GLP-1s have been eased, there are still large barriers for most consumers interested in taking these drugs
Foods provoking and alleviating symptoms in gastroparesis: patient experiences